Bavarian Nordic (BAVA) – aksjekurser og nyheter

Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development. In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination. In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia

Om Bavarian Nordic

Administrerende direktørPaul Chaplin

Ansatte1,91k

Grunnlagt1. juli 1992

Hovedkontor-

Sektor-

Nettstedbavarian-nordic.com

Alle verdier i DKK	sep. 2025	des. 2025	mars 2026	juni 2026
Inntekt	1,79 mrd.	1,45 mrd.	1,06 mrd.	2,03 mrd.
Varekostnad	901,84 mill.	866,52 mill.	583,64 mill.	803,15 mill.
Direkte driftskostnader	901,84 mill.	866,52 mill.	583,64 mill.	803,15 mill.
Utgifter til forskning og utvikling	133,20 mill.	181,74 mill.	175,14 mill.	163,43 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	415,41 mill.	352,14 mill.	306,07 mill.	319,05 mill.
Driftskostnader	548,52 mill.	533,88 mill.	481,21 mill.	482,48 mill.
Totale driftskostnader	1,45 mrd.	1,40 mrd.	1,06 mrd.	1,29 mrd.
Driftsinntekter	344,56 mill.	50,55 mill.	−7,01 mill.	748,77 mill.
Andre ikke-operasjonelle inntekter	−1,75 mill.	−1,74 mill.	−1,71 mill.	−1,74 mill.
EBT inkludert uvanlige elementer	1,17 mrd.	28,19 mill.	23,32 mill.	759,63 mill.
EBT uten uvanlige elementer	361,71 mill.	62,45 mill.	23,72 mill.	760,01 mill.
Kostnad for inntektsskatt	77,02 mill.	326,99 mill.	6,36 mill.	27,99 mill.
Faktisk avgiftssats	6,58 %	1 159,86 %	27,30 %	3,68 %
Andre driftskostnader	−88,00k	-	-	-
Nettoinntekt	1,09 mrd.	−298,80 mill.	16,95 mill.	731,64 mill.
Netto fortjenestemargin	60,89 %	−20,59 %	1,60 %	35,96 %
Resultat per aksje	-	−3,30	-	8,90
Rente- og investeringsinntekter	12,90 mill.	19,84 mill.	14,86 mill.	13,06 mill.
Rentekostnader	−1,37 mill.	−2,18 mill.	−1,41 mill.	−3,56 mill.
Netto rentekostnader	11,53 mill.	17,66 mill.	13,45 mill.	9,50 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	515,50 mill.	166,77 mill.	165,45 mill.	924,55 mill.
Gevinst eller tap ved salg av eiendeler	-	18,43 mill.	-	-

Spør om hva som helst